Karmanos Cancer Institute

From Wikipedia, the free encyclopedia
Barbara Ann Karmanos Cancer Institute
Karmanos Cancer Institute logo.jpg
Wikimedia | © OpenStreetMap
Geography
Location4100 John R, Detroit, Michigan, United States
Organization
Care systemNon-profit
TypeCancer
Affiliated universityWayne State University School of Medicine
Services
Beds123
History
Opened1943
Links
Websitehttp://www.karmanos.org
ListsHospitals in Michigan

The Barbara Ann Karmanos Cancer Institute, headquartered in Detroit, is the largest cancer research and provider network in Michigan and has 15 treatment locations.[1] It is one of 51 National Cancer Institute-designated comprehensive cancer treatment and research centers in the United States.[2] Affiliated with the Wayne State University School of Medicine, the institute has 1,000 staff members, including 300 doctors, and 100 researchers. The staff treats approximately 12,000 patients each year [3] and operates with a budget of $260 million.

Karmanos' vision is a world free of cancer and its mission is to lead in transformative cancer care, research and education through courage, commitment and compassion.[1]

Karmanos has one of the largest clinical trials programs in the nation, giving patients access to more than 250 treatments often available only at Karmanos.[4] It conducts 800 cancer-specific scientific investigations programs and clinical trials each year.[5] The institute has a Phase 1 program, a participating site in the Early Therapeutics Clinical Trials Network (ET-CTN) of the NCI.[4] Gerold Bepler is chief executive officer and president of KCI and Justin Klamerus[6] is president of Barbara Ann Karmanos Cancer Hospital & Network, overseeing clinical operations in Detroit, as well as the Karmanos cancer network across Michigan.[7]

History[]

Karmanos began as the Detroit Institute for Cancer Research in 1943 and was later named the Michigan Cancer Foundation, encompassing the Meyer L. Prentis Comprehensive Cancer Center of Metropolitan Detroit and the cancer programs of the Detroit Medical Center and Wayne State University. In 1995, the cancer center was named after Barbara Ann Karmanos, the late wife of Peter Karmanos Jr., former chairman and chief executive officer of Compuware Corporation. Barbara Ann Karmanos succumbed to breast cancer at the age of 46.

On October 30, 2013, Karmanos Cancer Institute and McLaren Health Care signed an agreement that created the largest cancer research and provider network in Michigan. The agreement was finalized in January 2014.[8]

Recognition[]

Karmanos has been named one of America's Best Hospitals for Cancer Care & Research by the Women's Choice Award for 2018. Previously, Karmanos had been ranked as one of America's Best Hospitals for Cancer Care by the Women's Choice Award, from 2011-2012, as well as 2014-2017.[9] It also won the Women's Choice Award for Patient Experience in 2017.[10]

Leadership[]

References[]

  1. ^ Jump up to: a b "About". www.karmanos.org. Retrieved 2016-11-23.
  2. ^ "Cancer Centers". www.cancer.gov. Retrieved 2017-06-02.
  3. ^ "FAQs". www.karmanos.org. Retrieved 2018-01-24.
  4. ^ Jump up to: a b "Clinical Trials". www.karmanos.org. Retrieved 2016-01-07.
  5. ^ [1] Archived 2009-07-09 at the Wayback Machine Retrieved 2009-07-01
  6. ^ "Justin Klamerus, M.D., appointed president of Karmanos Cancer Hospital". School of Medicine News. Wayne State University. 2017-01-18.
  7. ^ Jump up to: a b [2] Archived 2012-02-25 at the Wayback Machine Retrieved 2010-02-09
  8. ^ "Karmanos Cancer Institute and McLaren Health Care to Create Largest Cancer Research and Provider Network in Michigan". www.karmanos.org. Retrieved 2014-09-22.
  9. ^ "Barbara Ann Karmanos Cancer Institute receives 2018 Womens Choice Award as one of Americas Best Hospitals for Cancer Care Research". www.karmanos.org. Retrieved 2018-02-23.
  10. ^ "Home". www.karmanos.org. Retrieved 2017-06-02.
Retrieved from ""